76 related articles for article (PubMed ID: 7508141)
1. [Met-enkephalin and substance P. Comparison of CSF levels in patients with chronic pain based on a sampling procedure].
Guieu R; Tardy-Gervet MF; Giraud P; Boudouresque F
Rev Neurol (Paris); 1993; 149(6-7):398-401. PubMed ID: 7508141
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid concentrations of substance P and (met)enkephalin-Arg6-Phe7 during surgery and patient-controlled analgesia.
Sjöström S; Tamsen A; Hartvig P; Folkesson R; Terenius L
Anesth Analg; 1988 Oct; 67(10):976-81. PubMed ID: 2458686
[TBL] [Abstract][Full Text] [Related]
3. Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus.
Yaksh TL; Carmichael SW; Stoddard SL; Tyce GM; Kelly PJ; Lucas D; van Heerden JA; Ahlskog JE; Byer DE
J Lab Clin Med; 1990 Mar; 115(3):346-51. PubMed ID: 2313164
[TBL] [Abstract][Full Text] [Related]
4. Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
Yaksh TL; Sabbe MB; Lucas D; Mjanger E; Chipkin RE
J Pharmacol Exp Ther; 1991 Mar; 256(3):1033-41. PubMed ID: 1706428
[TBL] [Abstract][Full Text] [Related]
5. Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
Bourgoin S; Rostaing-Rigattieri S; Nguyen JP; Berberich E; Duvaldestin P; Fattaccini CM; Hamon M; Cesselin F
Clin Neuropharmacol; 1999; 22(4):231-8. PubMed ID: 10442254
[TBL] [Abstract][Full Text] [Related]
6. Release of beta-endorphin and methionine-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain. Effects of stimulation locus and site of sampling.
Young RF; Bach FW; Van Norman AS; Yaksh TL
J Neurosurg; 1993 Dec; 79(6):816-25. PubMed ID: 8246048
[TBL] [Abstract][Full Text] [Related]
7. [Kyotorphin like substance in human cerebrospinal fluid of patients with persistent pain].
Nishimura K; Kaya K; Hazato T; Ueda H; Satoh M; Takagi H
Masui; 1991 Nov; 40(11):1686-90. PubMed ID: 1766121
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of methionine-enkephalin-like substance in CSF from normal subjects and patients with pituitary adenoma (author's transl)].
Furui T; Kuwayama A; Kageyama N
No To Shinkei; 1980 Mar; 32(3):305-9. PubMed ID: 7370137
[TBL] [Abstract][Full Text] [Related]
9. [A study of the leucine enkephalin like substance and enkephalin degrading enzyme activity in human cerebrospinal fluid].
Hasumi K; Kobayashi S; Hazato T; Hase K; Kaya K
Masui; 1989 Sep; 38(9):1177-80. PubMed ID: 2810715
[TBL] [Abstract][Full Text] [Related]
10. Methionine-enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients.
Pezzoli G; Panerai AE; Di Giulio A; Longo A; Passerini D; Carenzi A
Neurology; 1984 Apr; 34(4):516-9. PubMed ID: 6199690
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
[TBL] [Abstract][Full Text] [Related]
12. Low calcitonin gene-related, peptide-like immunoreactivity in cerebrospinal fluid from chronic pain patients.
Lindh C; Liu Z; Welin M; Ordeberg G; Nyberg F
Neuropeptides; 1999 Dec; 33(6):517-21. PubMed ID: 10657534
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the levels of methionine enkephalin in the blood and CSF and of 5-hydroxyindoleacetic acid in the CSF, following intrathecal administration of morphine].
Seijo F; Melcón LF; Simó RM
Rev Esp Oncol; 1985; 32(3):529-38. PubMed ID: 2443950
[TBL] [Abstract][Full Text] [Related]
14. Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients.
Bourgoin S; Cesselin F; Gozlan H; Fattaccini CM; Tran MA; Montastruc JL; Rascol A; Hamon M
Clin Neuropharmacol; 1987 Oct; 10(5):434-42. PubMed ID: 2460234
[TBL] [Abstract][Full Text] [Related]
15. [Cerebrospinal fluid levels of leucine enkephalin and methionine enkephalin in patients with altered behavior].
Loeb C; Albano C; Serrati C
Schweiz Arch Neurol Neurochir Psychiatr; 1984; 134(1):29-40. PubMed ID: 6231720
[TBL] [Abstract][Full Text] [Related]
16. Met-enkephalin in the liver as a marker of hepatocellular damage in chronic viral hepatitis type B and C.
Cieśla A; Mach T; Pierzchała-Koziec K; Skwara P; Szczepański W
Adv Med Sci; 2006; 51():261-4. PubMed ID: 17357322
[TBL] [Abstract][Full Text] [Related]
17. Increased cerebrospinal fluid Met-enkephalin immunoreactivity in patients with chronic tension-type headache.
Langemark M; Bach FW; Ekman R; Olesen J
Pain; 1995 Oct; 63(1):103-107. PubMed ID: 8577479
[TBL] [Abstract][Full Text] [Related]
18. Substance P-like immunoreactivity and analgesic effects of vibratory stimulation on patients suffering from chronic pain.
Guieu R; Tardy-Gervet MF; Giraud P
Can J Neurol Sci; 1993 May; 20(2):138-41. PubMed ID: 7687513
[TBL] [Abstract][Full Text] [Related]
19. Elevation of substance P-like peptides in the CSF of psychiatric patients.
Rimón R; Le Grevés P; Nyberg F; Heikkilä L; Salmela L; Terenius L
Biol Psychiatry; 1984 Apr; 19(4):509-16. PubMed ID: 6203562
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.
Carpenter LL; Bayat L; Moreno F; Kling MA; Price LH; Tyrka AR; Kinkead B; Owens MJ; Nemeroff CB
Psychiatry Res; 2008 Jan; 157(1-3):123-9. PubMed ID: 17976740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
